Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
50%
Ph not_applicable
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations

NCT00397241
completednot_applicable

Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections

NCT02821390
completedphase_3

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

NCT00331240
completedphase_4

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

NCT00330577

Clinical Trials (4)

Showing 4 of 4 trials
NCT00397241Phase 4

24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations

Completed
NCT02821390Not Applicable

Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections

Completed
NCT00331240Phase 3

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

Completed
NCT00330577Phase 4

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4